Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Momenta prices IPO

MNTA raised $34.8 million in an IPO through the sale of 5.4

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE